Infratil has this morning released the presentation material for its annual Investor Day. Presentations will be recorded during the day and will be available to view on https://infratil.com/investors/reports-results-meetings-investor-days/ after the event.
Infratil's objective is to keep its stakeholders well informed about how its businesses are performing and how their delivery of strategic objectives is progressing.
Management will provide an update on Infratil's portfolio strategy, as well as providing views on the near-term outlook. There will also be a number of presentations from senior executives at Infratil’s portfolio businesses, including CDC, Gurīn Energy, Longroad Energy, One NZ and Wellington Airport.
Infratil’s FY2024 Proportionate EBITDAF guidance range of $820 million to $850 million is unchanged.
Enquiries should be directed to:
Mark Flesher
Investor Relations
Email: mark.flesher@infratil.com
Attachments:
Portfolio Update
Morrison Update
Renewable Energy Update
Longroad Energy Update
Gurīn Energy Update
Wellington Airport Update
Digital Update
One NZ Update
CDC Update
- Infratil Investor Day 2024 (PDF, 113.34KB)
- Infratil Investor Day 2024 - Portfolio Update (PDF, 929.12KB)
- Infratil Investor Day 2024 - Morrison Update (PDF, 1.95MB)
- Infratil Investor Day 2024 - Renewables Energy Update (PDF, 615.36KB)
- Infratil Investor Day 2024 - Longroad Energy Update (PDF, 1.42MB)
- Infratil Investor Day 2024 - Gurin Energy Update (PDF, 1.01MB)
- Infratil Investor Day 2024 - Wellington Airport Update (PDF, 5.39MB)
- Infratil Investor Day 2024 - Digital Update (PDF, 380.59KB)
- Infratil Investor Day 2024 - One NZ Update (PDF, 1.12MB)
- Infratil Investor Day 2024 - CDC Update (PDF, 2.45MB)
Related
Australian data centre update
Infratil Limited (NZX/ASX:IFT) notes it has recently received a number of investor queries regarding power delivery timelines for under-construction sites in Australia. CDC has confirmed that it has robust delivery
Infratil Newsletter - October 2026
Attached is a copy of the latest Infratil Newsletter for investors, with commentary on our recent Investor Day and developments at various portfolio companies. Enquiries should be directed to: Brett
CDC Independent Valuation – 30 September 2026
CDC Independent Valuation – 30 September 2026 CDC’s independent valuation was broadly flat with a mid-point valuation of A$18.5 billion at 30 September 2026. Continued progress in customer contracting and